CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
Condition: Breast Neoplasms Intervention: Drug: Taxanes or/and anthracycline-based therapy Sponsor: Shengjing Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research